Friday, October 16, 2009

Intraday Trading Calls for 16th October

Indian Stock Market may open positive and remains flat to positive for the day today.

Today's Intraday Stock Tips / Trading Calls (Keep strict Stop Loss for Each Trade):

SCRIP NAME

TRIGGER

PRICE

TARGET 1

TARGET 2

BRFL

Buy Above

220.15

225.45

232.00

Sell Below

216.35

211.70

206.00

GMR INFRA

Buy Above

75.25

77.55

80.00

Sell Below

73.70

71.35

69.00

BATA INDIA

Buy Above

181.65

185.75

191.00

Sell Below

179.15

175.25

170.00

3I INFOTECH

Buy Above

95.75

98.20

102.00

Sell Below

94.35

91.45

88.00

CAIRN INDIA

Buy Above

281.25

285.45

290.00

Sell Below

278.15

272.60

268.00

SELAN EXPLO

Buy Above

335.75

342.55

350.00

Sell Below

331.45

326.15

320.00

REL POWER

Buy Above

164.25

167.45

170.00

Sell Below

162.35

159.20

156.00

GOOD LUCK

Thursday, October 15, 2009

Intraday Trading Calls for 15th October

Indian Stock Market may open positive and remains flat to positive for the day today.

Today's Intraday Stock Tips / Trading Calls (Keep strict Stop Loss for Each Trade):

SCRIP NAME

TRIGGER

PRICE

TARGET 1

TARGET 2

ADSL

Buy Above

496.25

507.35

516.00

Sell Below

491.45

483.15

472.00

GMR INFRA

Buy Above

73.10

75.65

78.00

Sell Below

71.45

69.35

67.00

ALEMBIC

Buy Above

51.70

54.10

57.00

Sell Below

50.35

48.40

46.00

POWER GRID

Buy Above

112.25

115.70

120.00

Sell Below

110.20

106.70

102.00

CAIRN INDIA

Buy Above

280.65

285.45

290.00

Sell Below

277.35

272.60

268.00

SELAN EXPLO

Buy Above

341.20

347.45

354.00

Sell Below

337.45

332.70

326.00

PURVANKARA

Buy Above

121.05

125.35

130.00

Sell Below

119.40

115.55

111.00

Short to Medium Term Delivery Buy:

Buy L G Balakrishnan (500250) CMP Rs. 18.25/- Short Term Target Rs. 25/- and Med to Long Term Target Rs. 40/-.

GOOD LUCK

Wednesday, October 14, 2009

Stock Idea: Essel Propack Limited

Essel Propack Limited—Buy—38—INR
Sector — Packaging
Regd.Off. — Vasind P.O., Sahapur Taluka, Thane - 421604
Company overview—
Essel Propack Limited was incorporated in year 1982 is one of the largest manufacturers of laminated tubes in the world. Company is a part of the Essel Group, whose other interests include satellite communication, amusement parks. The company was started in technical collaboration with American National Can Company of US, Karl Magerle Kusnacht of Switzerland, and Kaito Chemicals of Japan. The company supplies tubes for toothpastes, cosmetics, pharmaceutical products, grease, adhesives and almost all segments of the packaging industry. Essel supplies the basic laminate or the web to its operations in Nepal, Egypt and China. Apart from this export revenue company also get royalty income of the sales and dividend from its overseas ventures. The laminated tubes manufacturing major is also looking at capacity expansion in its existing units in China, Egypt and Latin America, with an estimated investment of about $10 million. In the overseas operations the focus is going to be on the cosmetics and the oral care segment, so as to achieve critical mass. Company sees huge potential for laminated tube packaging in the pharmaceutical sector.
Products & services—
Essel Propack has state-of-the-art manufacturing facilities in 15 countries through 25 plants. Packaging products in a laminated tube gives it that competitive edge in the marketplace. Any product that requires attractive, safe and hygienic packaging can be packed in a laminated tube. Laminated tubes find applications in Toothpastes, Cosmetics & Toiletries, Pharmaceuticals, Food & Diary Products, Industrial Products and other products. In terms of growth engine, Company has got several successes in new segments such as cosmetics and pharmaceuticals. Company generates around 90% of its turnover from FMCG sector and 10% from pharmaceutical products.
Coextruded Seamless Tubes: Co-extruded seamless tubes make product stand out on a shelf and enhance its personality as a premium product.
Speciality Laminates and Webs for Laminated Tubes: Essel offers a wide range of laminates for several applications. Continuous innovation has enabled Essel to develop laminates that enable efficient running of tube making lines. The quality and performance of these laminates are top-notch.
Company plants are highly automated with the best technological machinery and systems available anywhere in the world. Company has put in place, two teams at its Technological Innovation Center. While one team focus on new products, the second works on process management. Primarily involved in developing new and improved products for customers, the first team works in close co-ordination with customers to enhance the product by experimenting with the various specifications associated with it. The second team works more with the existing product range. This team monitors machine efficiencies in all the manufacturing units and provides suitable recommendations. Together, the teams combine efforts with the marketing arm of the organization. Company also upgrades its testing facilities constantly to maintain its position at the frontier of technology.
China will be the major contributor in terms of volumes growth in future. Company has considerably enhanced its capacity in China. Except China, Western Europe and eastern European will be future growth drivers. Company has a manufacturing plant in US, East Germany, well positioned to serve western and Eastern Europe.
Recent Developments—
Essel Propack in april announced an acquisition of US based company Catheter & Disposables Technology (CDT), a supplier of specialized disposables medical devices. EPL has acquired 100% equity of CDT in an all cash deal through its US subsidiary, Tacpro. The buyout of CDT is in line with EPL’s strategic expansion plan, and will enable its medical business to establish and expand operations in Minnesota, the second largest medical device manufacturing region in USA.
Essel Propack and Ess Dee Aluminium, have joined a global race to acquire the packaging unit of Rio Tinto Alcan in april. The mining-to-metals major said it would sell the USD 5 billion packaging business as part of a move to focus on core areas. The joint bid is also being planned so that the two companies may split Rio Tinto’s unit subsequently, to merge with their own areas of operations. Morgan Stanley, the financial advisor to Rio Tinto, had suggested dividing the packaging unit to make it easier for interested companies and private equity firms to bid. Buyers could more likely be keen if the packaging division is broken up and offered for sale as smaller entities, the advisor is reported to have indicated. While sales of USD 5 billion or Rs 200 billion, is too big for any single company to acquire on its own. The packaging unit is the only section that has been immediately identified to be sold, while its bauxite, alumina, primary metal and engineered products divisions will all be absorbed into Rio Tinto.
Essel Propack (EPL) september, announced an acquisition of Minneapolis (US), based company Medical Engineering & Design (MED), a supplier of specialized disposable Medical Devices. EPL has acquired 74% equity of MED in an all cash deal through its US subsidiary - Tacpro. The rest will continued to be held by the existing promoter employees. MED has a diversified customer base with the provision of high quality medical device manufacturing services and reliable, on-time delivery of manufactured products. MED is supplier of custom products to the global medical device industry and delivers proven and effective solutions to catheter, extrusion and braid reinforced tubing needs of customers. The company is vertically integrated with its own in site extrusion, wire braiding, reflowing and assembly resulting in significant cost competitiveness and lead time savings to its customer.
Valuation—
Company is on expansion drive, it is looking for more acquisitions in international markets. At current market price, stock is trading at attractive valuation of 14.87 P/E multiple of its FY2010 estimated earnings par share. We recommend investors to “BUY” “Essel Propack Ltd” with medium to long-term investment prospective.
Source: Internet (Valuenotes by Abhishek Jain)

Stock Idea: Piramal Life Sciences Limited

Piramal Life Sciences Limited (PLSL) is an independent research driven drug company that was recently demerged from Piramal Healthcare Limited (Formerly know as Nicholas Piramal India Limited). PLSL was formerly the R&D division of NPIL. PLSL has state-of-the-art R&D laboratories built over 200,000 square-feet of space in Mumbai, India and over 300 scientists engaged in drug discovery and development.

The company, as expected remains in the red and in Q2FY10, the net loss has only increased. For Q2FY01, the company reported a net loss of Rs.31.47 crore v/s Rs.28.12 crore in Q1FY10 and loss of Rs.26.31 crore in Q2FY09. The only good part about the loss is that it does not have to pay income tax!

Despite the loss, the stock price has moved up sharply and this was mainly on account of the rise in revenue at Rs.2.55 crore as against Rs.1.73 crore in Q1FY10. This rise in revenue is very much in line what was expected since the first quarter. Right now, all that is happening in the company is development and no product is yet being sold commercially, so there arises no question of any major surge in income as such.

The company is focused on four therapeutic areas - cancer, diabetes, inflammation and infectious diseases. It currently has a pipeline of fourteen compounds. In cancer, it has three products that are in three Phase-II trials. In inflammation, three products are in Phase-II. In diabetes, the drugs are all in Phase-I and in infection, it has three Phase-II drugs.

Medical R&D is stated to be the ‘next big thing’ for India, given the lower costs on drug development. Compared to the USA or any other developed country, the R&D cost in India is just one-tenth. Hence, in the long run, it would be very good business for R&D units.

PLSL is expected to commercially launch its drug in fiscal 2011-12 and till then, it will continue to remain in losses. But once the drug is out and proves to be successful, it will become a goldmine.
Source: Internet (By S P Tulsian)

Intraday Trading Calls for 14th October

Indian Stock Market may open positive and remains flat to positive for the day today.

Today's Intraday Stock Tips / Trading Calls (Keep strict Stop Loss for Each Trade):

SCRIP NAME

TRIGGER

PRICE

TARGET 1

TARGET 2

APTECH

Buy Above

261.65

268.15

275.00

Sell Below

258.40

253.35

248.00

VOLTAS

Buy Above

162.25

165.10

168.00

Sell Below

160.35

157.55

154.00

BIOCON

Buy Above

264.25

270.55

278.00

Sell Below

260.45

256.35

252.00

NAGARJUN CONSTRUCT

Buy Above

165.75

170.15

174.00

Sell Below

164.25

160.45

156.00

CAIRN INDIA

Buy Above

263.75

269.40

275.00

Sell Below

260.10

255.70

251.00

SELAN EXPLO

Buy Above

325.15

332.75

340.00

Sell Below

321.05

315.35

308.00

WEBEL

Buy Above

364.20

372.65

380.00

Sell Below

360.10

354.25

85.00

GOOD LUCK

Tuesday, October 13, 2009

Stock idea: Jetking infotrain ltd.

Jetking Infotrain Ltd (Rs 205)
(BSE Code - 517063)
(P/E- 9.7, Equity - Rs5.89 cr, Market Cap - Rs120 cr)
Jetking Infotrain (JIL) is a Mumbai based company and is the leader in the field of hardware education in India. The name Jetking has been synonymous with hardware electronics and do-it-yourself radio and walkie- talkie kits for more than 40 years. The break-through opportunity,
which Jetking has successfully tapped, is the franchising of hardware and networking education courses across India. India has a huge market for the profile of students that Jetking targets, not only in the metros but also the Tier 1 & 2 cities. JIL is one of the leading hardware and Networking Training Institute and has trained over 4 lakhs students in its 125 centers spread across India. JIL has 60 years of experience in the industry and has faculty of 25,000 teachers who have trained and placed 4 lakhs students with top rated companies such as HP, IBM, Samsung, CMC, Reliance etc.
JIL's positioning as an educator in the Networking and Hardware space is quite strong, with the sector at an inflexion point and the company witnessing a 40% growth predominantly riding on the recession-proof status, as a result of its reach in almost every sector of the industry. JIL has an edge over the competitors as it guarantees 100% job placements, internationally benchmarked teaching methodology, ease of learning for non-technical students, personality development, practical training to enhance trouble shooting skills and has a strong leadership in the industry. JIL operates through a franchisee model which ascertains lower operating costs and scalable business model. In the year ended March 2009, JIL's revenues grew 25.5% to Rs 46.18 cr., whereas net profit grew 17% to Rs 12.44 cr. On a equity of 5.89 cr (Promoters' stake- 43%), the EPS stood at Rs 21.1 and the dividend of 50% was declared. JIL has an un- interrupted dividend paying track record since the past 10 years in addition to bonus shares issues-twice in the last 2 years. For the Q1 ended June 2009, JIL's revenues remained flat at Rs
11.13 cr. but EBITDA decreased by 31.5% on account of higher spending on other expenditure and courseware. Net profit was down 32.7% to 2.36 cr.. Going forward, JIL has plans to open 45
new centers in FY10 and also add 14 centers in China and Africa, which are markets, having large base of potential students, robust demand by recruiters and Government intent to invest in education sector. At current price of around Rs. 205, the stock trades at 9.7 times FY09 earnings and is available at a market cap of Rs. 120 cr. Looking at the opportunity size, the stock looks under priced and holds potential for appreciation. Accumulate on declines for good gains over the medium-long term.
Source: Internet (Valuenotes)

Saturday, October 10, 2009

Stock Idea: 3i Infotech

Business Profile
3i Infotech is a global IT company which offers a comprehensive range of software and IT solutions, including packaged applications, for the banking, financial services & insurance (BFSI), manufacturing, contracting, and retail & distribution industries. In addition, it offers a broad range of software services such as custom software development, IT consulting, IS and IT security consulting, enterprise application integration (EAI), and specialized services such as product reengineering, compliance consultancy, application rehabilitation and egovernance, among others.
Technical Analysis
The Stock has been trading in a consolidation phase for the past few sessions. In the last 3 sessions the stock has perform showing decent gains. A clear breakout above the level of 90 has occurred and it is expected to trade in the uptrend for the coming sessions.
Technical History After bottoming out at 26 in march09 the stock has made a high of 105. All the trends are giving bullish indication (Long term, Short term, Immediate term).The volumes are important aspect. Increasing volumes are confirming the uptrend. The Ascending triangle formation on the daily chart with rising trend line gives the immediate target of 117..The RSI on the weekly chart trading at 64 .The stock is trading above its 200EMA. The resistance is seen at 118-120.At these levels some correction is expected .Strategy for short term traders would be to book profit at these levels while long term investors can stay invested for the next target of 136.
Source: Internet (Valuenotes)

Disclaimer

The information in this publication is provided by http://www.moneybazzar.blogspot.com/ is intended for use for Readers & Traders . Every effort is made to provide accurate information, but http://www.moneybazzar.blogspot.com/ cannot guarantee the accuracy of the information or of the market analysis. This is a newsletter and is for informational purposes only. It is not a solicitation or offer to buy or sell futures. There is a high risk of loss in trading futures. You should not trade with money that you cannot afford to lose. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed on this newsletter. The past performance of any trading system or methodology is not necessarily indicative of future results.



free counter